FDA And CluePoints Sign New 3 Year Cooperative Research And Development Agreement To Assess Data Quality Using Statistical Modelling And Machine Learning

King of Prussia, PA: CluePoints, providers of leading statistical and AI-driven software solutions and Food and Drug Administration (FDA), today announced an extension to their long-standing collaboration. FDA and its stakeholders have a vested interest in ensuring the integrity of clinical trial data and the safety of participants while clinical research is being conducted. Clinical […]

CluePoints’ Site Profile & Oversight Tool (SPOT) shortlisted as finalist in 2024 Citeline Awards

King of Prussia, PA – March 25, 2024: CluePoints, providers of best-in-class statistical and AI-driven software solutions, has been shortlisted as finalist for the Best Sponsor-facing Technology Initiative in the 2024 Citeline Awards. CluePoints was recognized for its Site Profile & Oversight Tool (SPOT), – due to launch to the market in June 2024 – and was developed collaboratively, […]

Scope of Industry Risk-Based Quality Management (RBQM) Adoption Revealed

King of Prussia, PA: A comprehensive assessment of risk-based quality management (RBQM) adoption has revealed that slightly more than half of sponsors and contract research organizations (CROs) have adopted RBQM approaches. The Tufts Center for the Study of Drug Development (Tufts CSDD) conducted an online survey of bio-pharmaceutical and contract research organizations in collaboration with […]

CluePoints’ Audit Trail Review Project Wins Award for Innovation in the Management of Clinical Data Award

King of Prussia, PA – March 5, 2024: CluePoints, providers of best-in-class statistical and AI-driven software solutions, has won the 2024 Annual Association of Clinical Data Management (ACDM24) Innovation in the Management of Clinical Data Award. The Award recognized a collaborative project, led by Sebastiaan Hoppner, Sr. Research Scientist in Statistics, with CluePoints’ Statistical Research and Development Team, which […]

CluePoints wins SCRIP Awards for Best Contract Research Organization (CRO): Specialist Providers

King of Prussia, PA – October 17, 2023: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has won the Best Contract Research Organization (CRO): Specialist Providers category at 2023 Scrip Awards. The award, presented at The Dorchester in London, on Thursday 16th November 2023, was made in recognition of CluePoints’ innovative […]

Pioneering AI solutions and a commitment to industry-wide RBQM advancement secures CluePoints a finalist position in the 2023 SCRIP Awards

King of Prussia, PA – October 12, 2023: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has been shortlisted as a finalist in the Best Contract  Research Organization (CRO): Specialist Providers category of the 2023 Scrip Awards. The award category is for companies that provide niche services and is judged on […]

RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award

King of Prussia, PA – August 9, 2023: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, is proud to announce its RBQMLive event has won Best Product in the experiential/event marketing category of this year’s Sales and Marketing Technology Awards (Sammys). The Business Intelligence Group’s prestigious awards program is designed […]

Expert Speaker Lineup Revealed for Award Winning RBQM Event

King of Prussia, PA – August 1, 2023: CluePoints, the premier provider of Risk-Based Quality Management (RBQM) Software for clinical trials, has revealed the full agenda and speaker lineup for RBQMLive 2023. RBQMLive 2023 is a free, virtual event for anyone working with, interested in, or planning to adopt risk-based approaches to clinical trial management and oversight. […]

That’s a Wrap!
All three sessions are available on demand and ready to watch, revisit, save, or share.